Rivercell Raises $25M to Build an AI Virtual Cell
Paris-based biotechnology startup Rivercell has launched with a $25 million seed round to build an AI model capable of predicting how human cells respond to drugs and genetic changes. Led by HV, the financing will support Rivercell’s proprietary biological data platform, Paris wet lab and AI Virtual Cell program as the company targets a major…
